Name | Sales (Cr) | Profit (Cr) | EBITDA (Cr) | Financial Year |
---|---|---|---|---|
ICRA | 446.11 | 152.24 | 223.73 | MAR, 2024 |
CARE Ratings | 331.68 | 102.56 | 158.82 | MAR, 2024 |
CRISIL | 3,139.52 | 658.44 | 975.14 | DEC, 2023 |
Company | Market Cap (Cr) | Chg (%) | PE (x) | PB (x) | EV to Sales (x) | EV to EBITDA (x) | Dividend Yield (%) |
---|---|---|---|---|---|---|---|
CRISIL | 32,410.68 | 2.93 | 49.87 | 14.42 | 10.29 | 36.07 | 1.22 |
ICRA | 5,835.09 | 3.97 | 38.73 | 5.93 | 12.77 | 39.05 | 1.65 |
CARE Ratings | 3,109.32 | -3.10 | 30.93 | 4.34 | 9.27 | 27.64 | 1.73 |